Beating the Odds: A Successful Pregnancy in a Patient With ALK-Rearranged Lung Cancer on Alectinib

The management of oncogene-driven non–small cell lung cancer (NSCLC) during pregnancy presents unique challenges due to limited safety data on targeted therapies. Anaplastic lymphoma kinase (ALK)-rearranged NSCLC is a rare but increasingly recognized entity in young women, including during pregnancy...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicholas Yeo, Fiona Johnston, Louise Fay, Paul Lilburn, Debra Kennedy, Helen Barrett, Antonia Shand, Giselle Kidson-Gerber, Monica Tang, Daniel Challis, Benjamin Y. Kong
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/carm/9032427
Tags: Add Tag
No Tags, Be the first to tag this record!